Tenofovir in Indian children.
We describe our experience with tenofovir-based antiretroviral therapy in seven HIV-infected children after failure of first line antiretroviral drugs, or due to adverse effects to other antiretrovirals. For follow-up period of average 3.4 years, none had adverse effects or failure of treatment, indicating that tenofovir has good renal and gastrointestinal safety profile in HIV-infected Indian children and adolescents.
Pediatric HIV, TB and Liver Clinic, Bai Jerbai Wadia Hospital for Children, Mumbai, India. docjagdishkat@gmail.com.
Jagdish
J
Kathwate
Ira
I
Shah
D000293:Adolescent; D044966:Anti-Retroviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008297:Male; D000068698:Tenofovir / Q000009:adverse effects / Q000627:therapeutic use*
D044966:Anti-Retroviral Agents; D000068698:Tenofovir